|
|
|
|
| Advertisement |
 |
|
|
|
|
| Advertisement |
 |
|
|
| Industry update |
|
//
The UK's Medicines Discovery Catapult has appointed Dr. Robin Brown as its new Chairman, succeeding founding Chairman Professor Graham Boulnois.
//
DBV Technologies (Montrouge, France) appointed Kevin Trapp as Chief Commercial Officer.
//
Roberto Pucci, Head of Human Resources at Sanofi (Paris, France), will retire after more than nine years of service. He will be succeeded in the post by Caroline Luscombe, who joins Sanofi on October 1, 2018.
//
ObsEva SA (Geneva, Switzerland and Boston, MA) announced the appointment of a Chief Commercial Officer, Wim Souverijns, who will be based at the company headquarters in Geneva.
//
Silence Therapeutics (London, UK) appointed Dr. David Horn Solomon as Chief Executive Officer.
//
Chugai Pharma Europe (CPE) appointed Troy Robinson as Managing Director of its wholly owned commercial subsidiary, Chugai Pharma UK (CPU). Troy will oversee all UK commercial operations, working alongside colleagues in Germany and France to bolster CPE's commercial activity across Europe.
//
Prescient Healthcare Group appointed Dr. Paul Harney as President, North America. He has also been named to Prescient's Board of Directors.
|
|
|
|
|
